LEGISLATIVE BUDGET BOARD Austin, Texas FISCAL NOTE, 81ST LEGISLATIVE REGULAR SESSION February 26, 2009 TO: Honorable Lois W. Kolkhorst, Chair, House Committee on Public Health FROM: John S. O'Brien, Director, Legislative Budget Board IN RE:HB142 by McClendon (Relating to disease control programs to reduce the risk of certain communicable diseases.), As Introduced No significant fiscal implication to the State is anticipated. The bill would add Subchapter J to Chapter 81, Health and Safety Code, to authorize local health authorities or organizations that contract with a county, municipality, hospital district, or other local governmental entity charged with protecting public health to establish a disease control program. The requirements for the program are included in the bill. A local health authority or organization would be allowed to charge a program participant a fee for each hypodermic needle or syringe used in the program not to exceed 150 percent of the actual cost of the needle or syringe. A local health authority or organization that operates a disease control program established under the provisions of the bill would be required to annually submit certain information about the effectiveness of the program to the Department of State Health Services. The bill would establish exceptions to offenses related to possession or delivery of drug paraphernalia as manufacture, possession, and distribution apply to the disease control program. Any administrative costs to the state regarding information submitted to the Department of State Health Services could be absorbed within existing resources. Local Government Impact Costs to a local health authority or organization would vary and would be partially offset by fees charged. It is assumed that an authority or organization would establish a program only if sufficient resources existed within the authority's or organization's budget. Source Agencies:537 State Health Services, Department of LBB Staff: JOB, CL, DB, BM
LEGISLATIVE BUDGET BOARD
Austin, Texas
FISCAL NOTE, 81ST LEGISLATIVE REGULAR SESSION
February 26, 2009
TO: Honorable Lois W. Kolkhorst, Chair, House Committee on Public Health FROM: John S. O'Brien, Director, Legislative Budget Board IN RE:HB142 by McClendon (Relating to disease control programs to reduce the risk of certain communicable diseases.), As Introduced
TO: Honorable Lois W. Kolkhorst, Chair, House Committee on Public Health
FROM: John S. O'Brien, Director, Legislative Budget Board
IN RE: HB142 by McClendon (Relating to disease control programs to reduce the risk of certain communicable diseases.), As Introduced
Honorable Lois W. Kolkhorst, Chair, House Committee on Public Health
Honorable Lois W. Kolkhorst, Chair, House Committee on Public Health
John S. O'Brien, Director, Legislative Budget Board
John S. O'Brien, Director, Legislative Budget Board
HB142 by McClendon (Relating to disease control programs to reduce the risk of certain communicable diseases.), As Introduced
HB142 by McClendon (Relating to disease control programs to reduce the risk of certain communicable diseases.), As Introduced
No significant fiscal implication to the State is anticipated.
No significant fiscal implication to the State is anticipated.
The bill would add Subchapter J to Chapter 81, Health and Safety Code, to authorize local health authorities or organizations that contract with a county, municipality, hospital district, or other local governmental entity charged with protecting public health to establish a disease control program. The requirements for the program are included in the bill. A local health authority or organization would be allowed to charge a program participant a fee for each hypodermic needle or syringe used in the program not to exceed 150 percent of the actual cost of the needle or syringe. A local health authority or organization that operates a disease control program established under the provisions of the bill would be required to annually submit certain information about the effectiveness of the program to the Department of State Health Services. The bill would establish exceptions to offenses related to possession or delivery of drug paraphernalia as manufacture, possession, and distribution apply to the disease control program. Any administrative costs to the state regarding information submitted to the Department of State Health Services could be absorbed within existing resources.
The bill would add Subchapter J to Chapter 81, Health and Safety Code, to authorize local health authorities or organizations that contract with a county, municipality, hospital district, or other local governmental entity charged with protecting public health to establish a disease control program. The requirements for the program are included in the bill. A local health authority or organization would be allowed to charge a program participant a fee for each hypodermic needle or syringe used in the program not to exceed 150 percent of the actual cost of the needle or syringe.
A local health authority or organization that operates a disease control program established under the provisions of the bill would be required to annually submit certain information about the effectiveness of the program to the Department of State Health Services.
The bill would establish exceptions to offenses related to possession or delivery of drug paraphernalia as manufacture, possession, and distribution apply to the disease control program.
Any administrative costs to the state regarding information submitted to the Department of State Health Services could be absorbed within existing resources.
Local Government Impact
Costs to a local health authority or organization would vary and would be partially offset by fees charged. It is assumed that an authority or organization would establish a program only if sufficient resources existed within the authority's or organization's budget.
Source Agencies: 537 State Health Services, Department of
537 State Health Services, Department of
LBB Staff: JOB, CL, DB, BM
JOB, CL, DB, BM